BGMS — Bio Green Med Solution Share Price
0.000.00%
Last trade - 00:00- $16.72m
- $12.44m
- $0.04m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.6 | ||
| Price to Tang. Book | 4.6 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1,671.82 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -148.61% | ||
| Return on Equity | -277.67% | ||
| Operating Margin | -54110% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | 0.42 | 0.04 | 0.1 | 0.1 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Bio Green Med Solution, Inc., formerly Cyclacel Pharmaceuticals, Inc., is a diversified company engaged in both the fire protection and biopharmaceutical industries. It develops medicines based on cell cycle, epigenetics and mitosis biology. Its Polo-like kinase 1 (PLK1) is a serine/threonine kinase with a central role in cell division and an important regulator of the DNA damage checkpoint. PLK1 overexpression correlates with poor patient prognosis in several tumors, including esophageal, gastric, leukemia, non-small cell lung cancer, ovarian, and squamous cell cancers, as well as MYC-amplified cancers. Plogosertib is a novel, small molecule, selective and potent PLK1 inhibitor. Its Fire Safety division specializes in supplying and trading various protective and fire safety equipment to both domestic and international markets. It provides fire safety products, including fire extinguishers, foam systems, fire-resistant doors, personal protective equipment, and fire safety apparel.
Directors
- Christopher Henney NEC (80)
- Spiro Rombotis PRE (62)
- Paul Mcbarron CFO (60)
- Mark Kirschbaum SVP (60)
- Samuel Barker IND (78)
- Gregory Hradsky IND (60)
- Brian Schwartz IND
- Lloyd Sems IND (49)
- Robert Spiegel IND (71)
- Karin Walker IND (57)
- Last Annual
- December 31st, 2024
- Last Interim
- June 30th, 2025
- Incorporated
- January 5th, 1996
- Public Since
- January 1st, 1996
- No. of Shareholders
- 14
- No. of Employees
- 12
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 3,497,537
- Address
- 200 Connell Dr Ste 1500, BERKELEY HEIGHTS, 07922
- Web
- https://cyclacel.com/
- Phone
- +1 9085177330
- Auditors
- Bush & Associates CPA LLC
Upcoming Events for BGMS
Similar to BGMS
ABVC Biopharma
NASDAQ Capital Market
Acesis Holdings
NASDAQ Capital Market
Achieve Life Sciences
NASDAQ Capital Market
Aclarion
NASDAQ Capital Market
Acurx Pharmaceuticals
NASDAQ Capital Market
FAQ
What is the Bio Green Med Solution share price?
As of Today at 19:36 UTC, shares in Bio Green Med Solution are trading at $4.78. This share price information is delayed by 15 minutes.
How has the Bio Green Med Solution share price performed this year?
Shares in Bio Green Med Solution last closed at $4.78 and the price had moved by -97.83% over the past 365 days. In terms of relative price strength the Bio Green Med Solution share price has underperformed the S&P500 Index by -98.15% over the past year.
What are the analyst and broker recommendations for Bio Green Med Solution?
The overall consensus recommendation for Bio Green Med Solution is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Bio Green Med Solution dividend yield?
Bio Green Med Solution does not currently pay a dividend.
Does Bio Green Med Solution pay a dividend?
Bio Green Med Solution does not currently pay a dividend.
When does Bio Green Med Solution next pay dividends?
Bio Green Med Solution does not currently pay a dividend.
How do I buy Bio Green Med Solution shares?
To buy shares in Bio Green Med Solution you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Bio Green Med Solution?
As of the previous close price of $4.78, shares in Bio Green Med Solution had a market capitalisation of $16.72m.
Where are Bio Green Med Solution shares listed?
Here are the trading details for Bio Green Med Solution:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: BGMS
What kind of share is Bio Green Med Solution?
Based on an overall assessment of its quality, value and momentum Bio Green Med Solution is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Bio Green Med Solution share price forecast for 2025?
The analyst consensus target price for shares in Bio Green Med Solution is $1.00. That is 79.08% below the last closing price of $4.78.
Analysts covering Bio Green Med Solution currently have a consensus Earnings Per Share (EPS) forecast of -$1.18 for the next financial year.
Find out moreWhat is the trend in the Bio Green Med Solution share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bio Green Med Solution. Over the past six months, its share price has underperformed the S&P500 Index by -92.98%.
As of the last closing price of $4.78, shares in Bio Green Med Solution were trading -88.86% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Bio Green Med Solution PE Ratio?
The Bio Green Med Solution PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $4.78.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Bio Green Med Solution?
Bio Green Med Solution's management team is headed by:
- Christopher Henney - NEC
- Spiro Rombotis - PRE
- Paul Mcbarron - CFO
- Mark Kirschbaum - SVP
- Samuel Barker - IND
- Gregory Hradsky - IND
- Brian Schwartz - IND
- Lloyd Sems - IND
- Robert Spiegel - IND
- Karin Walker - IND